Tonix Pharmaceuticals Holding C (TNXP) Financials
TNXP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 139.3 million | 18.4 million |
2023-06-30 | 159.7 million | 19.3 million |
2023-03-31 | 179.1 million | 13.7 million |
2022-12-31 | 225.7 million | 18.5 million |
TNXP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -25.2 million | 2.1 million |
2023-06-30 | -25.2 million | 2.4 million |
2023-03-31 | -36.7 million | 2.8 million |
2022-12-31 | -27.0 million | 2.7 million |
TNXP Net Income
No data available :(
TNXP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 6.9 million | - | 1.2 million |
2023-06-30 | 25.6 million | - | 1.3 million |
2023-03-31 | 72.0 million | - | 1.0 million |
2022-12-31 | 120.2 million | - | 760000 |
TNXP Shares Outstanding
TNXP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 1.8 million | 21.1 million | 8.7 million | - |
2023-06-30 | 1.8 million | 22.0 million | 7.0 million | - |
2023-03-31 | 3.8 million | 26.5 million | 7.4 million | - |
2022-12-31 | 4.7 million | 24.7 million | 8.1 million | - |
TNXP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 4.0 million | 2.4 million |
2023-06-30 | - | 29.0 million |
2023-03-31 | 33.9 million | 893000 |
2022-12-31 | - | 836000 |
TNXP
Price: $0.18
52 week price:
Earnings Per Share: -6.85 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 943700
Ebitda: -5.8 millionMarket Capitalization: 17.5 million